Haemonetics Corporation (HAE)
USD 63.85
(1.37%)
USD 63.85
(1.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 317.2 Million USD | 22.29% |
| 2023 | 259.37 Million USD | -11.48% |
| 2022 | 293.02 Million USD | -9.17% |
| 2021 | 322.61 Million USD | 19.36% |
| 2020 | 270.27 Million USD | 39.08% |
| 2019 | 194.33 Million USD | 20.86% |
| 2018 | 160.79 Million USD | -9.12% |
| 2017 | 176.92 Million USD | -4.95% |
| 2016 | 186.14 Million USD | -11.81% |
| 2015 | 211.07 Million USD | 6.79% |
| 2014 | 197.66 Million USD | 7.55% |
| 2013 | 183.78 Million USD | 56.86% |
| 2012 | 117.16 Million USD | 38.84% |
| 2011 | 84.38 Million USD | 5.55% |
| 2010 | 79.95 Million USD | 4.48% |
| 2009 | 76.52 Million USD | 17.03% |
| 2008 | 65.38 Million USD | 5.81% |
| 2007 | 61.79 Million USD | 13.24% |
| 2006 | 54.57 Million USD | 2.79% |
| 2005 | 53.08 Million USD | 1.63% |
| 2004 | 52.23 Million USD | -20.62% |
| 2003 | 65.8 Million USD | -2.14% |
| 2002 | 67.24 Million USD | 24.51% |
| 2001 | 54 Million USD | -9.71% |
| 2000 | 59.81 Million USD | 0.03% |
| 1999 | 59.8 Million USD | -3.08% |
| 1998 | 61.7 Million USD | 11.98% |
| 1997 | 55.1 Million USD | -2.82% |
| 1996 | 56.7 Million USD | -5.5% |
| 1995 | 60 Million USD | 45.28% |
| 1994 | 41.3 Million USD | 36.3% |
| 1993 | 30.3 Million USD | -0.98% |
| 1992 | 30.6 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 317.2 Million USD | 22.29% |
| 2024 Q2 | 285.83 Million USD | -1.17% |
| 2024 Q1 | 289.2 Million USD | 11.5% |
| 2024 Q3 | 304.02 Million USD | 6.37% |
| 2024 Q4 | 317.2 Million USD | 4.33% |
| 2023 Q4 | 259.37 Million USD | 1.42% |
| 2023 Q2 | 254.68 Million USD | -8.35% |
| 2023 Q3 | 255.75 Million USD | 0.42% |
| 2023 Q1 | 277.88 Million USD | -5.17% |
| 2023 FY | 259.37 Million USD | -11.48% |
| 2022 Q4 | 293.02 Million USD | -4.16% |
| 2022 Q2 | 322.66 Million USD | -1.18% |
| 2022 Q1 | 326.5 Million USD | 1.2% |
| 2022 FY | 293.02 Million USD | -9.17% |
| 2022 Q3 | 305.74 Million USD | -5.24% |
| 2021 FY | 322.61 Million USD | 19.36% |
| 2021 Q1 | 294.51 Million USD | 8.97% |
| 2021 Q2 | 305.22 Million USD | 3.64% |
| 2021 Q3 | 299.71 Million USD | -1.81% |
| 2021 Q4 | 322.61 Million USD | 7.64% |
| 2020 Q3 | 254.16 Million USD | 3.95% |
| 2020 Q2 | 244.5 Million USD | 10.16% |
| 2020 Q1 | 221.95 Million USD | 14.21% |
| 2020 FY | 270.27 Million USD | 39.08% |
| 2020 Q4 | 270.27 Million USD | 6.34% |
| 2019 Q4 | 194.33 Million USD | 15.04% |
| 2019 Q2 | 163.58 Million USD | -6.7% |
| 2019 FY | 194.33 Million USD | 20.86% |
| 2019 Q1 | 175.32 Million USD | 9.04% |
| 2019 Q3 | 168.93 Million USD | 3.27% |
| 2018 Q4 | 160.79 Million USD | 1.23% |
| 2018 Q1 | 173.89 Million USD | -1.72% |
| 2018 FY | 160.79 Million USD | -9.12% |
| 2018 Q2 | 168.59 Million USD | -3.05% |
| 2018 Q3 | 158.84 Million USD | -5.78% |
| 2017 Q1 | 189.43 Million USD | 1.77% |
| 2017 Q3 | 188.48 Million USD | -3.1% |
| 2017 Q2 | 194.51 Million USD | 2.68% |
| 2017 Q4 | 176.92 Million USD | -6.13% |
| 2017 FY | 176.92 Million USD | -4.95% |
| 2016 Q2 | 207.64 Million USD | -1.65% |
| 2016 Q1 | 211.13 Million USD | 0.03% |
| 2016 Q3 | 203.86 Million USD | -1.82% |
| 2016 Q4 | 186.14 Million USD | -8.69% |
| 2016 FY | 186.14 Million USD | -11.81% |
| 2015 Q4 | 211.07 Million USD | -0.67% |
| 2015 Q1 | 207.48 Million USD | 4.97% |
| 2015 Q2 | 209.41 Million USD | 0.93% |
| 2015 Q3 | 212.49 Million USD | 1.47% |
| 2015 FY | 211.07 Million USD | 6.79% |
| 2014 FY | 197.66 Million USD | 7.55% |
| 2014 Q4 | 197.66 Million USD | -5.57% |
| 2014 Q3 | 209.33 Million USD | 1.99% |
| 2014 Q2 | 205.25 Million USD | 4.36% |
| 2014 Q1 | 196.67 Million USD | 7.01% |
| 2013 Q3 | 180.03 Million USD | 3.76% |
| 2013 FY | 183.78 Million USD | 56.86% |
| 2013 Q4 | 183.78 Million USD | 2.08% |
| 2013 Q1 | 126.84 Million USD | 8.26% |
| 2013 Q2 | 173.5 Million USD | 36.79% |
| 2012 Q3 | 107.91 Million USD | 6.38% |
| 2012 FY | 117.16 Million USD | 38.84% |
| 2012 Q2 | 101.44 Million USD | 6.83% |
| 2012 Q1 | 94.96 Million USD | 12.53% |
| 2012 Q4 | 117.16 Million USD | 8.57% |
| 2011 Q3 | 81.91 Million USD | -4.76% |
| 2011 Q1 | 84.57 Million USD | 5.78% |
| 2011 FY | 84.38 Million USD | 5.55% |
| 2011 Q4 | 84.38 Million USD | 3.02% |
| 2011 Q2 | 86 Million USD | 1.7% |
| 2010 FY | 79.95 Million USD | 4.48% |
| 2010 Q4 | 79.95 Million USD | 1.46% |
| 2010 Q3 | 78.8 Million USD | 2.17% |
| 2010 Q2 | 77.13 Million USD | 1.37% |
| 2010 Q1 | 76.09 Million USD | -0.56% |
| 2009 Q4 | 76.52 Million USD | 4.03% |
| 2009 FY | 76.52 Million USD | 17.03% |
| 2009 Q3 | 73.55 Million USD | 0.51% |
| 2009 Q1 | 71.19 Million USD | 8.88% |
| 2009 Q2 | 73.18 Million USD | 2.79% |
| 2008 Q4 | 65.38 Million USD | 2.41% |
| 2008 FY | 65.38 Million USD | 5.81% |
| 2008 Q1 | 68.2 Million USD | 10.38% |
| 2008 Q2 | 66.06 Million USD | -3.14% |
| 2008 Q3 | 63.84 Million USD | -3.36% |
| 2007 Q1 | 55.56 Million USD | 1.81% |
| 2007 Q3 | 59.68 Million USD | 1.28% |
| 2007 FY | 61.79 Million USD | 13.24% |
| 2007 Q4 | 61.79 Million USD | 3.55% |
| 2007 Q2 | 58.92 Million USD | 6.05% |
| 2006 Q3 | 56.31 Million USD | -2.2% |
| 2006 FY | 54.57 Million USD | 2.79% |
| 2006 Q2 | 57.58 Million USD | 2.83% |
| 2006 Q1 | 55.99 Million USD | 5.48% |
| 2006 Q4 | 54.57 Million USD | -3.09% |
| 2005 FY | 53.08 Million USD | 1.63% |
| 2005 Q4 | 53.08 Million USD | 1.15% |
| 2005 Q1 | 52.58 Million USD | 0.68% |
| 2005 Q2 | 50.71 Million USD | -3.57% |
| 2005 Q3 | 52.48 Million USD | 3.5% |
| 2004 Q2 | 58.72 Million USD | -8.5% |
| 2004 FY | 52.23 Million USD | -20.62% |
| 2004 Q3 | 56.08 Million USD | -4.5% |
| 2004 Q4 | 52.23 Million USD | -6.86% |
| 2004 Q1 | 64.17 Million USD | -2.47% |
| 2003 Q1 | 74.44 Million USD | 10.71% |
| 2003 Q3 | 70.13 Million USD | -2.25% |
| 2003 Q2 | 71.75 Million USD | -3.61% |
| 2003 FY | 65.8 Million USD | -2.14% |
| 2003 Q4 | 65.8 Million USD | -6.18% |
| 2002 Q2 | 61.98 Million USD | 9.38% |
| 2002 Q3 | 63.28 Million USD | 2.1% |
| 2002 Q1 | 56.67 Million USD | 4.93% |
| 2002 Q4 | 67.24 Million USD | 6.25% |
| 2002 FY | 67.24 Million USD | 24.51% |
| 2001 Q2 | 52.96 Million USD | -8.06% |
| 2001 Q1 | 57.61 Million USD | -3.68% |
| 2001 Q3 | 52.76 Million USD | -0.38% |
| 2001 FY | 54 Million USD | -9.71% |
| 2001 Q4 | 54 Million USD | 2.35% |
| 2000 Q4 | 59.81 Million USD | 1.04% |
| 2000 Q2 | 59.5 Million USD | 2.94% |
| 2000 Q3 | 59.2 Million USD | -0.5% |
| 2000 Q1 | 57.8 Million USD | -3.34% |
| 2000 FY | 59.81 Million USD | 0.03% |
| 1999 Q4 | 59.8 Million USD | -6.56% |
| 1999 Q1 | 64.5 Million USD | 4.54% |
| 1999 Q2 | 67.7 Million USD | 4.96% |
| 1999 Q3 | 64 Million USD | -5.47% |
| 1999 FY | 59.8 Million USD | -3.08% |
| 1998 FY | 61.7 Million USD | 11.98% |
| 1998 Q2 | 65.1 Million USD | 10.34% |
| 1998 Q3 | 60.8 Million USD | -6.61% |
| 1998 Q4 | 61.7 Million USD | 1.48% |
| 1998 Q1 | 59 Million USD | 7.08% |
| 1997 FY | 55.1 Million USD | -2.82% |
| 1997 Q4 | 55.1 Million USD | 17.74% |
| 1997 Q1 | 58.3 Million USD | 2.82% |
| 1997 Q2 | 52.5 Million USD | -9.95% |
| 1997 Q3 | 46.8 Million USD | -10.86% |
| 1996 FY | 56.7 Million USD | -5.5% |
| 1996 Q2 | 58.4 Million USD | -2.34% |
| 1996 Q1 | 59.8 Million USD | -0.33% |
| 1996 Q4 | 56.7 Million USD | -0.87% |
| 1996 Q3 | 57.2 Million USD | -2.05% |
| 1995 FY | 60 Million USD | 45.28% |
| 1995 Q4 | 60 Million USD | 7.14% |
| 1995 Q1 | 46.7 Million USD | 13.08% |
| 1995 Q3 | 56 Million USD | 9.16% |
| 1995 Q2 | 51.3 Million USD | 9.85% |
| 1994 FY | 41.3 Million USD | 36.3% |
| 1994 Q2 | 35.4 Million USD | 13.46% |
| 1994 Q3 | 40.5 Million USD | 14.41% |
| 1994 Q4 | 41.3 Million USD | 1.98% |
| 1994 Q1 | 31.2 Million USD | 2.97% |
| 1993 Q3 | 29.4 Million USD | -2.0% |
| 1993 Q2 | 30 Million USD | -0.33% |
| 1993 Q4 | 30.3 Million USD | 3.06% |
| 1993 Q1 | 30.1 Million USD | -1.63% |
| 1993 FY | 30.3 Million USD | -0.98% |
| 1992 Q3 | 32.7 Million USD | 18.05% |
| 1992 FY | 30.6 Million USD | 0.0% |
| 1992 Q4 | 30.6 Million USD | -6.42% |
| 1992 Q1 | 26.5 Million USD | 0.0% |
| 1992 Q2 | 27.7 Million USD | 4.53% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alcon Inc. | 2.32 Billion USD | 86.335% |
| AptarGroup, Inc. | 513.05 Million USD | 38.174% |
| Baxter International Inc. | 2.82 Billion USD | 88.768% |
| Becton, Dickinson and Company | 3.27 Billion USD | 90.309% |
| Bausch + Lomb Corporation | 1.02 Billion USD | 69.144% |
| Envista Holdings Corp | 258.8 Million USD | -22.566% |
| ResMed Inc. | 822.25 Million USD | 61.423% |
| Teleflex Incorporated | 626.21 Million USD | 49.346% |
| Warby Parker Inc. | 62.23 Million USD | -409.692% |
| West Pharmaceutical Services, Inc. | 434.7 Million USD | 27.03% |